MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

+ + data and comment + +, page-55

  1. 22,691 Posts.
    re: + + annual report . agm is on 29 oct + + http://stocknessmonster.com/news-item?S=MBP&E=ASX&N=224675

    There are more applications to come:
    Extract:
    "Veterinary Applications of AOD9604
    There are quantifiable economic benefits to pig
    farmers in reducing the amount of back fat on
    their pigs, as the price paid to the farmer for the
    carcass increases with reduced levels of back fat.

    There is also a very large potential market for
    treatment of obesity in domestic pets.

    It is expected that AOD9604 could be
    manufactured for such applications at very
    low marginal cost in the form of an animal
    food additive containing AOD9604 in a
    genetically modified (transgenic) seed.

    In the period under review, the Company
    chose a technology partner, based in the US,
    with expertise in transgenic seed production.
    Transgenic rice lines were established and when
    the plants are harvested in the next year, the
    Company may have the opportunity to test
    the concept in animal trials".








    The Annual General Meeting of the Company will be held at 10.00 a.m. on Friday, 29 October 2004 at Level 23, Rialto South Tower, 525 Collins Street, Melbourne,
    Victoria.
    The Annual Report and Notice of Annual General Meeting will be despatched to shareholders on 24 September 2004.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.